Top Abstract Purchase Related
Home
>
Node
>
Subnode

The role of adiponectin in pathogenesis of metabolic syndrome and cardiovascular disease

Kozłowska, A.; Kowalska, I.

Endokrynologia Polska 57(6): 626-632

2006

ISSN/ISBN: 0423-104X
PMID: 17253436
Document Number: 602474
The aim of this review is to present the up-to-date data about adiponectin and it's role in pathogenesis of cardiovascular disease. Adiponectin is a hormone derived from adipose tissue which regulates energy metabolism, and plays an important role in the pathogenesis of insulin resistance. Serum levels of adiponectin are reduced in obesity, hypertension, metabolic syndrome and type 2 diabetes. Moreover, plasma adiponectin concentration is inversely associated with LDL-cholesterol, TG and is positively related to HDL-cholesterol. Recent studies have indicated that adiponectin has antiinflammatory and antiatherogenic properties. Review of the data confirmed the hypothesis that adiponectin plays an important role in pathogenesis of cardiovascular disease.

Document emailed within 1 workday
Secure & encrypted payments

Soebijanto, N.; Waspadji, S. 2010: Adiponectin levels and its role in insulin resistance among adult women with metabolic syndrome Acta Medica Indonesiana 42(4): 187-191
Heine, R.J. 2002: Postprandial glucose peaks in the pathogenesis of cardiovascular disease in diabetes mellitus; implications for metabolic control Nederlands Tijdschrift Voor Geneeskunde 146(26): 1251-2; Author Reply 1252-3
Wolffenbuttel, B.H.R. 2002: Postprandial glucose peaks in the pathogenesis of cardiovascular disease in diabetes mellitus; implications for metabolic control Nederlands Tijdschrift Voor Geneeskunde 146(14): 654-658
Vitarius, J.A. 2005: The metabolic syndrome and cardiovascular disease Mount Sinai Journal of Medicine new York 72(4): 257-262
Adam, F.M.S.; Nara, M.G.B.; Adam, J.M.F. 2006: Fasting insulin, adiponectin, hs-CRP levels, and the components of metabolic syndrome Acta Medica Indonesiana 38(4): 179-184
Bano, K.A.; Batool, A. 2007: Metabolic syndrome, cardiovascular disease and type-2 diabetes JPMA. Journal of the Pakistan Medical Association 57(10): 511-515
Tabak, O.; Gelişgen, R.; Cicekçi, H.; Senateş, E.; Erdenen, F.; Müderrisoğlu, C.; Aral, H.; Uzun, H. 2012: Circulating levels of adiponectin, orexin-A, ghrelin and the antioxidant paraoxonase-1 in metabolic syndrome Minerva Medica 103(4): 323-329
Siemińska, L.; Wojciechowska, C.; Foltyn, W.; Kajdaniuk, D.; Kos-Kudła, B.; Marek, B.; Nasiek, M.; Nowak, M.; Strzelczyk, J.; Zemczak, A. 2006: The relation of serum adiponectin and leptin levels to metabolic syndrome in women before and after the menopause Endokrynologia Polska 57(1): 15-22
Guo, L.; Hu, X-shu.; Guo, Z-rong.; Kang, G-dong.; Wu, M.; Zhou, H. 2009: Association and interaction between the components of metabolic syndrome and cardiovascular disease Zhonghua Xin Xue Guan Bing Za Zhi 37(7): 644-647
Virstiuk, N.G.; Seniutovich, N.R. 2013: The role of growth factors in pathogenesis of hepatic lesions in patients with metabolic syndrome and chronic non-calculous cholecystitis Klinicheskaia Meditsina 91(9): 22-25
Kravchun, P.; Kadykova, O.; Gabisoniia, T. 2012: The role of adipokines in formation of lipid and carbohydrate metabolic disorders in patients with cardiovascular disease Georgian Medical News 213: 26-31
Ford, E.S. 2005: Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence Diabetes Care 28(7): 1769-1778
Sluiter, W.; Pietersma, A.; Lamers, J.M.; Koster, J.F. 1993: Leukocyte adhesion molecules on the vascular endothelium: their role in the pathogenesis of cardiovascular disease and the mechanisms underlying their expression Journal of Cardiovascular Pharmacology 22(Suppl): S37-S44
Panina, E.B.; Botvinnik, V.S. 1992: The role of autonomic dysfunction in the pathogenesis of lipid and lipoprotein metabolic disorders in patients with metabolic-alimentary obesity Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 92(5-12): 22-24
Tuev, A.V.; Ibragimova, E.I.; Solov'ev, O.V. 1991: The sick sinus syndrome and lipid peroxidation: its possible role in the pathogenesis of the disease Terapevticheskii Arkhiv 63(4): 77-82
Hurjui, D.M.; Niţă, O.; Graur, L.I.; Mihalache, L.; Popescu, D.S.; Graur, M. 2012: The central role of the non alcoholic fatty liver disease in metabolic syndrome Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 116(2): 425-431
Chitalia, N.; Raja, R.B.; Bhandara, T.; Agrawal, P.; Kaski, J.C.; Jha, V.; Banerjee, D. 2010: Serum adiponectin and cardiovascular risk in chronic kidney disease and kidney transplantation Journal of Nephrology 23(1): 77-84
Kriachkova, A.A.; Savel'eva, S.A.; Kutyrina, I.M. 2011: The role of lipid metabolism disorders in kidney disease in metabolic syndrome associated with obesity Terapevticheskii Arkhiv 83(8): 54-58
Kutyrina, I.M.; Kriachkova, A.A.; Savel'eva, S.A. 2012: The role of hyperinsulinemia and insulin resistance in development of chronic kidney disease in patients with metabolic syndrome Terapevticheskii Arkhiv 84(6): 32-36
Cheung, L.P.; Ma, R.C.W.; Lam, P.M.; Lok, I.H.; Haines, C.J.; So, W.Y.; Tong, P.C.Y.; Cockram, C.S.; Chow, C.C.; Goggins, W.B. 2008: Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndrome Human Reproduction 23(6): 1431-1438